Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Lake Street Sticks to Their Buy Rating for Sensus Healthcare (SRTS)

Tipranks - Tipranks - Sat Nov 8, 2025

In a report released today, Ben Haynor from Lake Street reiterated a Buy rating on Sensus Healthcare, with a price target of $6.00.

Meet Your ETF AI Analyst

According to TipRanks, Haynor is an analyst with an average return of -15.3% and a 27.75% success rate. Haynor covers the Healthcare sector, focusing on stocks such as Owlet, Treace Medical Concepts, and Tactile Systems Technology.

Currently, the analyst consensus on Sensus Healthcare is a Strong Buy with an average price target of $7.33.

See Insiders’ Hot Stocks on TipRanks >>

Based on Sensus Healthcare’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $7.32 million and a GAAP net loss of $1.04 million. In comparison, last year the company earned a revenue of $9.24 million and had a net profit of $1.61 million

Read More on SRTS:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).